31Jul
Department of Justice fines pharmaceutical company
Compliance Today (August 2020) - On May 7, the Department of Justice’s Antitrust Division announced a deferred prosecution agreement, in which Apotex Corp. agreed to pay a $24.1 million criminal penalty for price-fixing. The Florida-based company conspired with competitors to increase and maintain the price of pravastatin, a commonly prescribed cholesterol medication that lowers the risk of heart disease and stroke....
By:
Health Care Compliance Association (HCCA)
Related
Fencing Company's Mistreatment of Black Employee, Including Racial Slurs and Noose Display, Forced H...
Read More >
Today, the Supreme Court of the United States issued the following three opinions: Intel Corp. Inve...
Read More >
On January 1, 2020, the Artificial Intelligence Video Interview Act went into effect in Illinois. T...
Read More >
Our Environment, Land Use & Natural Resources Group deconstructs the California State Water Resource...
Read More >
On July 31, 2019, in the case of Nano Nagle School v Daly, the Supreme Court of Ireland delivered it...
Read More >
In December 2019, U.S. lawmakers passed the SECURE (Setting Every Community Up for Retirement Enhanc...
Read More >